The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
Abstract
A new edition of the WHO classification of tumours of the CNS was published in 2021. Although the previous edition of this classification was published just 5 years earlier, in 2016, rapid advances in our understanding of the molecular underpinnings of CNS tumours, including the diversity of clinically relevant molecular types and subtypes, necessitated a new classification system. Compared with the 2016 scheme, the new classification incorporates even more molecular alterations into the diagnosis of many tumours and reorganizes gliomas into adult-type diffuse gliomas, paediatric-type diffuse low-grade and high-grade gliomas, circumscribed astrocytic gliomas, and ependymal tumours. A number of new entities are incorporated into the 2021 classification, especially tumours that preferentially or exclusively arise in the paediatric population. Such a substantial revision of the WHO scheme will have major implications for the diagnosis and treatment of patients with CNS tumours. In this Perspective, we summarize the main changes in the classification of diffuse and circumscribed gliomas, ependymomas, embryonal tumours and meningiomas, and discuss how each change will influence post-surgical treatment, clinical trial enrolment and cooperative studies. Although the 2021 WHO classification of CNS tumours is a major conceptual advance, its implementation on a routine clinical basis presents some challenges that will require innovative solutions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glioma is the most prevalent central nervous system tumor and is classified into four grades, grades I, II, III, and IV, by the World Health Organization [44].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [44]
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella‐Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,703
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,063
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
DNA methylation-based classification of central nervous system tumours
Capper, D., Jones, D., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chávez, L., Reuß, D., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,114
Ostrom, Q. T., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz‐Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,716
Cited by
Sorted by citations
Wen, P. Y., van den Bent, M. J., Youssef, G., Cloughesy, T. F., Ellingson, B. M., Weller, M., Galanis, E., Barboriak, D. P., de Groot, J., Gilbert, M. R., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01059 · Cited by 519
Self-citationWang, W., Li, T., Cheng, Y., Li, F., Qi, S., Mao, M., Wu, J., Liu, Q., Zhang, X., Li, X., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.03.013 · Cited by 246
Sosinsky, A., Ambrose, J. C., Cross, W. C. H., Turnbull, C., Henderson, S. J., Jones, J. L., Hamblin, A. D., Arumugam, P., Chan, G. C., Chubb, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02682-0 · Cited by 193
Sun, T., Liu, B., Li, Y., Wu, J., Cao, Y., Yang, S., Tan, H., Cai, L., Zhang, S., Qi, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02815-w · Cited by 154
Sahm, F., Brandner, S., Bertero, L., Capper, D., French, P. J., Figarella-Branger, D. F., Giangaspero, F., Haberler, C., Hegi, M. E., Kristensen, B. W., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad100 · Cited by 113
Guo, X., Gu, L., Li, Y., Zheng, Z., Chen, W., Wang, Y., Wang, Y., Xing, H., Shi, Y., Liu, D., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1200815 · Cited by 97
Duan, M., Cao, R., Yang, Y., Chen, X., Liu, L., Ren, B., Wang, L., & Goh, B.-C. (2024) · Cancers · doi:10.3390/cancers16193300 · Cited by 84
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1
Hirschler, L., Sollmann, N., Schmitz‐Abecassis, B., Pinto, J., Arzanforoosh, F., Barkhof, F., Booth, T. C., Calvo‐Imirizaldu, M., Cassia, G. D. S. E., Chmelík, M., et al. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28662 · Cited by 83
Chiu, F.-Y., & Yen, Y. (2023) · Biomarker Research · doi:10.1186/s40364-023-00476-7 · Cited by 94
Adult type diffuse gliomas in the new 2021 WHO Classification
Antonelli, M., & Poliani, P. L. (2022) · Pathologica · doi:10.32074/1591-951x-823 · Cited by 72
Faisal, S. M., Comba, A., Varela, M. L., Argento, A. E., Brumley, E. K., Abel, C. C., Castro, M. G., & Lowenstein, P. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005069 · Cited by 58
Zhou, W., Jiang, Y., Xu, Q., Chen, L., Qiao, H., Wang, Y., Lai, J., Zhong, D., Zhang, Y., Li, W., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01069-3 · Cited by 60
Zhong, Y., Geng, F., Mazik, L., Yin, X., Becker, A. P., Mohammed, S., Su, H., Xing, E., Kou, Y., Chiang, C.-Y., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101706 · Cited by 47
Redlich, J.-P., Feuerhake, F., Weis, J., Schaadt, N. S., Teuber‐Hanselmann, S., Buck, C., Luttmann, S., Eberle, A., Nikolin, S., Appenzeller, A., et al. (2024) · npj Imaging · doi:10.1038/s44303-024-00020-8 · Cited by 49
Guo, X., Shi, Y., Liu, D., Li, Y., Chen, W., Wang, Y., Wang, Y., Xing, H., Xia, Y., Li, J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1131642 · Cited by 41
G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells
Cao, Y., Liu, B., Cai, L., Li, Y., Huang, Y., Zhou, Y., Sun, X., Yang, W., & Sun, T. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14191 · Cited by 39
Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?
d’Amati, A., Bargiacchi, L., Rossi, S., Carai, A., Bertero, L., Barresi, V., Errico, M. E., Buccoliero, A. M., Asioli, S., Marucci, G., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1268038 · Cited by 39
Pöhlmann, J., Weller, M., Marcellusi, A., Grabe-Heyne, K., Krott-Coi, L. M., Rabar, S., & Pollock, R. F. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1368606 · Cited by 43
Molecular pathology and clinical implications of diffuse glioma
Chai, R., Fang, S., Pang, B., Liu, Y., Wang, Y., Zhang, W., & Jiang, T. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002446 · Cited by 34
Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma
Chai, R., Yan, H., An, S., Pang, B., Chen, H., Mu, Q., Zhang, K., Zhang, Y.-W., Liu, Y., Liu, X., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13153 · Cited by 35
5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy
Howley, R., Chandratre, S., & Chen, B. (2023) · Bioengineering · doi:10.3390/bioengineering10040496 · Cited by 33
Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials
Sharma, N., Mallela, A. N., Shi, D. D., Tang, L. W., Abou‐Al‐Shaar, H., Gersey, Z. C., Zhang, X., McBrayer, S. K., & Abdullah, K. G. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad053 · Cited by 33
Role of N6-methyladenosine methylation in glioma: recent insights and future directions
Li, C., Li, B., Wang, H., Qu, L., Liu, H., Weng, C., Han, J., & Li, Y. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00514-0 · Cited by 36
Ritter, M., Blume, C., Tang, Y., Patel, A., Patel, B., Berghaus, N., Benotmane, J. K., Kueckelhaus, J., Yabo, Y. A., Zhang, J., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00904-z · Cited by 36
Exosomes in Glioma: Unraveling Their Roles in Progression, Diagnosis, and Therapy
Yang, S., Sun, Y., Liu, W., Zhang, Y., Sun, G., Xiang, B., & Yang, J. (2024) · Cancers · doi:10.3390/cancers16040823 · Cited by 34
Song, B., Wang, X., Qin, L., Hussain, S., & Liang, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107308 · Cited by 31
Motevasseli, M., Darvishi, M., Khoshnevisan, A., Zeinalizadeh, M., Saffar, H., Bayat, S., Najafi, A., Abbaspour, M. J., Mamivand, A., Olson, S. B., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01837-5 · Cited by 33
Li, X., Tie, J.-J., Sun, Y., Gong, C., Deng, S., Chen, X., Li, S., Wang, Y., Wang, Z., Wu, F., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03194-6 · Cited by 32
Goenka, A., Song, X., Tiek, D. M., Iglesia, R. P., Lu, M., Zeng, C., Horbinski, C., Zhang, W., Hu, B., & Cheng, S. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad065 · Cited by 28
Self-citationChen, L., Zhang, J., Chi, C., Che, W., Dong, G., Wang, J., Du, Y., Wang, R., Zhu, Z., Tian, J., et al. (2024) · Theranostics · doi:10.7150/thno.91554 · Cited by 28
Long non-coding RNA in glioma: novel genetic players in temozolomide resistance
Roh, J., Im, M., Kang, J., Youn, B., & Kim, W. (2023) · Animal Cells and Systems · doi:10.1080/19768354.2023.2175497 · Cited by 28
Sun, T., Liu, B., Cao, Y., Li, Y., Cai, L., & Yang, W. (2024) · Cancer Letters · doi:10.1016/j.canlet.2023.216605 · Cited by 27
Zhan, Y., Hao, Y., Wang, X., & Guo, D. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104682 · Cited by 28
Dendrimer Technology in Glioma: Functional Design and Potential Applications
Gaitsch, H., Hersh, A. M., Alomari, S., & Tyler, B. (2023) · Cancers · doi:10.3390/cancers15041075 · Cited by 27
Song, J., Xu, Z., Fan, Q., Sun, Y., & Lin, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1198713 · Cited by 26
Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastoma
Sojka, C., Wang, H. V., Bhatia, T. N., Li, Y., Chopra, P., Sing, A., Voss, A. J., King, A. T., Wang, F., Joseph, K., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01583-9 · Cited by 24
Alex David, S., Begum, A., Kalilulah, S. I., Ruth Naveena, N., Rajathi, K., & Hemalatha, D. (2024) · International Conference on Power, Energy, Control and Transmission Systems (ICPECTS) · doi:10.1109/icpects62210.2024.10780014 · Cited by 25
Li, S., Chen, S., Li, Y., Sun, W., Li, J., Deng, H., Ding, H., Wang, Z., Zhu, L., Liu, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq5331 · Cited by 27
Microplastics and nanoplastics in brain tumours and the healthy human brain
Li, R. Q., Lin, F., Zhao, X., Wang, J., Teng, M., Li, C., Ma, L., Zhong, H., Chen, Y., Tang, W., et al. (2026) · Nature Health · doi:10.1038/s44360-026-00091-4 · Cited by 25
Porter, A. B., Wen, P. Y., & Polley, M. C. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_389322 · Cited by 23
Self-citationGroff, K. J., Patel, R. V., Feng, Y., Ghosh, H. S., Chavez, M. A. M., O’Brien, J., Chen, W. C., Nitturi, V., Save, A., Youngblood, M. W., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(25)00422-x · Cited by 20
Self-citationRecent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms
Fath, M. K., Babakhaniyan, K., Anjomrooz, M., Jalalifar, M.-R., Alizadeh, S. D., Pourghasem, Z., Oshagh, P. A., Azargoonjahromi, A., Almasi, F., Manzoor, H. Z., et al. (2022) · Vaccines · doi:10.3390/vaccines10091448 · Cited by 23
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials
Rahman, R., Janowski, M., Killick-Cole, C. L., Singleton, W., Campbell, E. L., Walczak, P., Khatua, S., Faltings, L., Symons, M. H., Schneider, J. R., et al. (2023) · Cancers · doi:10.3390/cancers15030857 · Cited by 21
Rahban, M., Joushi, S., Bashiri, H., Saso, L., & Sheibani, V. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1325214 · Cited by 21
Stepanenko, A. A., Sosnovtseva, A. O., Valikhov, M. P., Chernysheva, A. A., Abramova, O. V., Naumenko, V., & Chekhonin, V. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1326757 · Cited by 20
Interactions between microglia and glioma in tumor microenvironment
Tao, J., Dong, Y. J., Shao, W., Zhou, D., Wang, Y., Hou, S., Deng, K., & Lin, N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1236268 · Cited by 23
Stretching boundaries in neurophysiological monitoring
Hou, B., & Liu, X. (2023) · BMEMat · doi:10.1002/bmm2.12054 · Cited by 18
Usuzaki, T., Takahashi, K., Inamori, R., Morishita, Y., Takagi, H., Shizukuishi, T., Toyama, Y., Abe, M., Ishikuro, M., Obara, T., et al. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106001 · Cited by 18
Faisal, S. M., Clewner, J. E., Stack, B., Varela, M. L., Comba, A., Abbud, G., Motsch, S., Castro, M. G., & Lowenstein, P. R. (2024) · Advanced Science · doi:10.1002/advs.202309796 · Cited by 18
Yang, J., Shen, L., Yang, J., Qu, Y., Gong, C., Zhou, F., Liu, Y., Luo, M., & Zhao, L. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-906 · Cited by 17
Hu, J., Sa, X., Yang, Y., Han, Y., Wu, J., Sun, M., Shafi, S., Ahmad, N., Siraj, S., Yang, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06185-z · Cited by 16
Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors
Halfpenny, A. M., & Wood, M. D. (2023) · Pediatric Neurosurgery · doi:10.1159/000528957 · Cited by 16
Pandey, A., Chandla, A., Mekonnen, M. A., Hovis, G. E. A., Teton, Z. E., Patel, K. S., Everson, R. G., Wadehra, M., & Yang, I. (2024) · Cancers · doi:10.3390/cancers16112131 · Cited by 16
Śledzińska, P., Furtak, J., Bebyn, M. G., & Serafin, Z. (2024) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2024.06.004 · Cited by 16
Song, Z., Zhao, L., Fang, W., Guo, S., Xu, A., Zhan, Z., Cai, Y., Xue, S., Chai, P., Jiang, Q., et al. (2023) · Nano Research · doi:10.1007/s12274-023-5807-7 · Cited by 15
Classification of the Type of Brain Tumor in MRI Using Xception Model
Cobilla, R., Dichoso, J. C., Miñon, A. B., Pascual, A. K., Abisado, M., Huyo-a, S. L., & Sampedro, G. A. (2023) · International Conference on Electronics, Information, and Communication (ICEIC) · doi:10.1109/iceic57457.2023.10049979 · Cited by 14
Weiser, A., Bergman, A. S., Machaalani, C., Bennett, J., Roth, P., Reimann, R., Nazarian, J., & Stücklin, A. G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1254645 · Cited by 17
Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
Kitagawa, Y., Kobayashi, A., Cahill, D. P., Wakimoto, H., & Tanaka, S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189102 · Cited by 13
Dasram, M. H., Naidoo, P., Walker, R. B., & Khamanga, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031371 · Cited by 11
Functional profiling of murine glioma models highlights targetable immune evasion phenotypes
Mikolajewicz, N., Tatari, N., Wei, J., Savage, N. J., Farias, A. G., Dimitrov, V., Chen, D. Y., Zador, Z. E., Dasgupta, K., Aguilera-Uribe, M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02831-w · Cited by 14
Liu, Y., Peng, Y., Song, C., Liu, Z., Yang, X., Bian, S., Xiao, X., Li, H., Wang, J., Sun, Z., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf123 · Cited by 12
Medical Treatment of Pediatric Low-Grade Glioma
Lim, Y. J. (2022) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2022.0039 · Cited by 12
Hu, P., Xu, L., Qi, Y., Yan, T., Ye, L., Wen, S., Yuan, D., Zhu, X., Deng, S., Liu, X., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183032 · Cited by 12
Du, P., Liu, X., Wu, X., Chen, J., Cao, A., & Geng, D. (2023) · Brain Sciences · doi:10.3390/brainsci13060912 · Cited by 12
Richardson, T. E., Yokoda, R. T., Rashidipour, O., Vij, M., Snuderl, M., Brem, S. S., Hatanpaa, K. J., McBrayer, S. K., Abdullah, K. G., Umphlett, M., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad085 · Cited by 12
Li, Y., Liu, B., Cao, Y., Cai, L., Zhou, Y., Yang, W., & Sun, T. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176274 · Cited by 12
de la Nava, D., Ausejo‐Mauleon, I., Laspidea, V., González-Huarriz, M., Lacalle, A., Casares, N., Zalacaín, M., Marrodán, L., García-Moure, M., Ochoa, M. C., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae066 · Cited by 12
Liu, C., Yang, W., Chien, C.-H., Wu, C.-L., Chuang, J., Chen, P., Chu, J., Cheng, S. M., Qiu, L.-Y., Chang, Y.-C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06784-6 · Cited by 12
Tozzi, A. E., Croci, I., Voicu, I. P., Dotta, F., Colafati, G. S., Carai, A., Fabozzi, F., Lacanna, G., Premuselli, R., & Mastronuzzi, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1285775 · Cited by 11
Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resection
Jia, L., Han, Z. W., Ma, C., Chi, H., Jia, D., Zhang, K., Feng, Z., Han, B., Qi, M., Li, G., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52138 · Cited by 11
Spinal Cord Astroblastoma With EWSR1-BEND2 Fusion in Female Patients
Fu, L., Lao, I. W., Huang, L., Ou, L., Yuan, L., Li, Z., Li, S., Hu, W., & Xi, S. (2024) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000002298 · Cited by 11
Zhao, S., Sun, Z., Xia, M., Guo, B., Qu, Y., Wang, J., Zhong, Z., & Meng, F. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113764 · Cited by 11
Gao, P., Jiang, H., Du, Y., Shu, Y., Wan, Y.-W., Yin, E., Wu, J., Liang, X.-X., Wang, S.-D., Ding, Z.-H., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01585-9 · Cited by 12
Sha, Y., Yan, Q., Tan, Y. Q., Wang, X., Zhang, H., & Yang, G. (2023) · Cancers · doi:10.3390/cancers15051440 · Cited by 11
Zhang, H., Zhang, H., Liu, X., Deng, H.-Z., Zhang, Y., Tang, X.-M., Lin, F., & Huang, B. (2024) · Canadian Association of Radiologists Journal · doi:10.1177/08465371241238917 · Cited by 10
Li, Y., Cao, Y., He, L., Wu, J., Cai, L., Zhou, Y., Li, H., Yang, W., & Sun, T. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167876 · Cited by 10
Carenza, C., Franzese, S., Castagna, A., Terzoli, S., Simonelli, M., Persico, P., Bello, L., Nibali, M. C., Pessina, F., Kunderfranco, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1074762 · Cited by 11
MAPK9 is Correlated with a Poor Prognosis and Tumor Progression in Glioma
Yang, X., Jia, Q., Liu, X., Wu, W., Han, Y., Zou, Z., Li, M., Fan, D., Song, J., & Chen, L. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803063 · Cited by 10
Feng, F., Sun, C., Wang, X., Zhang, H., & Cheng, P. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2199553 · Cited by 10
Morshed, R. A., Nguyen, M., Cummins, D. D., Saggi, S. S., Young, J. S., Haddad, A. F., Goldschmidt, E., Chang, E. F., McDermott, M. W., Berger, M. S., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad007 · Cited by 10
Chen, W., Zhang, T., & Zhang, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-67341-x · Cited by 9
NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K /Akt activation
Zhang, A., Peng, S., Sun, S., Ye, S., Zhao, Y., & Wu, Q. (2024) · Cancer Medicine · doi:10.1002/cam4.70100 · Cited by 9
Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Rechberger, J. S., Toll, S. A., Biswas, S., You, H. B., Chow, W. D., Kendall, N. A. S., Navalkele, P. D., & Khatua, S. (2025) · Cancers · doi:10.3390/cancers17030439 · Cited by 12
Bai, J., Cui, B., Li, F., Han, X., Yang, H., & Lu, J. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01729-7 · Cited by 9
Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma
Pang, F., Zhang, L., Li, M., Yi, X., Wang, Y., Yang, P., Wen, B., Jiang, J., Teng, Y., Yang, X., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00666-3 · Cited by 9
Molecular Profiling and Targeted Therapies in Gliomas
Felistia, Y., & Wen, P. Y. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01299-7 · Cited by 9
Self-citationMueller, S., Fangusaro, J., Thomas, A. O., Jacques, T. S., Bandopadhayay, P., de Blank, P. M. K., Packer, R. J., Fouladi, M., Meeteren, A. Y. N. S., Jones, D., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad227 · Cited by 9
Self-citationSerra, R., Smith, S. J., Rowlinson, J., Gorelick, N. L., Moloney, C., McCrorie, P., Veal, G. J., Berry, P., Chalmers, A. J., Suk, I., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02878-2 · Cited by 10
Low-intensity ultrasound: A novel technique for adjuvant treatment of gliomas
Fang, Y. R., Zhang, G., Bai, Z., Yan, Y., Song, X., Zhao, X., Yang, P., & Zhang, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113394 · Cited by 9
Leal, R. B., Mann, J., Pinto‐Junior, V. R., Oliveira, M. V., Osterne, V. J. S., Wolin, I. A. V., Nascimento, A. P. M., Welter, P. G., Ferreira, V. M. S., Silva, A. A., et al. (2022) · Molecules · doi:10.3390/molecules27207089 · Cited by 9
The value of multiparametric MRI radiomics in predicting IDH genotype in glioma before surgery
Liang, Y., Liu, W., Bai, D., Hu, J., & Wang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1265672 · Cited by 8
Silva, F. F. V. E., Domenico, M. D., Caponio, V. C. A., Pérez‐Sayáns, M., Camolesi, G. C. V., Rojo-Álvarez, L. I., Ballini, A., Garcı́a, A. G., Padín-Iruegas, E., & Peñaranda, J. M. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010612 · Cited by 8
Zerweck, L., Würtemberger, U., Klose, U., Reisert, M., Richter, V., Nägele, T., Staber, D., Han, T., Shen, M., Xie, C., et al. (2025) · Cancers · doi:10.3390/cancers17050876 · Cited by 8
Wang, J., Yang, L., Qi, H.-Y., Wang, L., Wei, S., Yuan, Y., Ge, J., Li, A., Yan, Z., Li, L. M., et al. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104168 · Cited by 8
Ubukata, R., Ohishi, T., Kaneko, M. K., Suzuki, H., & Kato, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178302 · Cited by 8
An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
Ye, L., Gu, L., Zheng, Z., Zhang, X., Xing, H., Guo, X., Chen, W., Wang, Y., Wang, Y., Liang, T., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1179761 · Cited by 8
Hazari, P. P., Yadav, S. K., Kumar, P., Dhingra, V., Rani, N., Kumar, R., Singh, B., & Mishra, A. K. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00091 · Cited by 8
Du, P., Wu, X., Liu, X., Chen, J., Cao, A., & Geng, D. (2023) · Cancers · doi:10.3390/cancers15205094 · Cited by 8
Álvarez-Vázquez, A., San‐Segundo, L., Cerveró-García, P., Flores-Hernández, R., Ollauri-Ibáñez, C., Segura‐Collar, B., Hubert, C. G., Morrison, G. M., Pollard, S. M., Lathia, J. D., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae060 · Cited by 8
LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B
Dong, N., Qi, W., Wu, L., Li, J., Zhang, X., Wu, H., Zhang, W., Jiang, J., Zhang, S., Fu, W., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03058-z · Cited by 8
Metadata
- Authors
- Horbinski, C., Berger, T., Packer, R. J., & Wen, P. Y.
- Affiliations
- Northwestern University (US)
- Brigham and Women's Hospital (US)
- Children's National (US)
- Corresponding author
- Horbinski, Craig
- Venue
- Nature Reviews Neurology
- Published
- 2022-06-21
- Volume
- 18
- Issue
- 9
- Pages
- 515-529
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W4283213286
- Cited by
- 312
- References
- 125
- Citations by year
- 2026: 59 · 2025: 83 · 2024: 86 · 2023: 71 · 2022: 12
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P50CA221747, K12CA090354)
- National Institute of Neurological Disorders and Stroke (R01NS118039, R01NS102669, R01NS117104)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
- Keywords
- diffuse glioma, ependymoma, embryonal tumors, meningioma, pediatric brain tumors, inclusion and exclusion criteria, postoperative care
- MeSH terms
- Brain Neoplasms, Child, Glioma, Humans, Meningeal Neoplasms, Meningioma, World Health Organization, Central Nervous System Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
